We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » Apotex Receives Closeout Letter, Resumes Shipping Generics to US
Apotex Receives Closeout Letter, Resumes Shipping Generics to US
May 24, 2011
Canadian generic-drug maker Apotex has received a closeout letter from the FDA, lifting an import alert for the company’s Etobicoke, Ontario facility, and paving the way for it to resume exports to the U.S.